Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.42 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.42 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.41 |
| ▸ | UTS2R | Q9UKP6 | 3/20 | 0.40 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | VNN1 | O95497 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | PLD2 | O14939 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6408289 | 0.99 | GAA (0.43) | GAAROCK2ROCK1HCRTR2UTS2R | |
| SCHEMBL6410424 | 0.89 | ROCK2 (0.52) | ROCK2ROCK1HCRTR2UTS2RPLD2 | |
| SCHEMBL6410284 | 0.89 | UTS2R (0.52) | GAAROCK2ROCK1HCRTR2UTS2R | |
| SCHEMBL6412889 | 0.89 | ROCK2 (0.49) | ROCK2ROCK1HCRTR2UTS2RLMNA | |
| Hydrochloric Acid SCHEMBL6410108 | 0.89 | ROCK2 (0.51) | ROCK2ROCK1HCRTR2UTS2RPLD2 | |
| SCHEMBL6409647 | 0.88 | ROCK2 (0.46) | ROCK2ROCK1HCRTR2UTS2RCHRNB2 | |
| SCHEMBL6409428 | 0.88 | MAPK1 (0.44) | GAAROCK2ROCK1HCRTR2PTGER4 | |
| Hydrochloric Acid SCHEMBL6412847 | 0.88 | UTS2R (0.51) | GAAROCK2ROCK1HCRTR2UTS2R | |
| SCHEMBL6410451 | 0.88 | POLB (0.46) | ROCK2ROCK1HCRTR2POLBALDH1A1 | |
| Hydrochloric Acid SCHEMBL6408427 | 0.88 | ROCK2 (0.48) | ROCK2ROCK1HCRTR2UTS2RLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050075326-A1 | Spiro compounds and methods for the modulation of chemokine receptor activity | VIROCHEM PHARMA INC (CA) | 2005-04-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075326-A1 | Spiro compounds and methods for the modulation of chemokine receptor activity | CXCR1, CXCR4, CXCR2 | GAA 4238/4885ROCK2 1735/4885ROCK1 1002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.